Expanded Access and Right to Try: The Impact of Recent Legislative Changes
May 30, 2018
Author: Kate Gallin Heffernan, Marylana Saadeh Helou and Robert Romanchuk
Kate Gallin Heffernan, Partner at Verrill Dana, LLP; Marylana Saadeh Helou, Associate at Verrill Dana, LLP; and Robert Romanchuk, IRB Chair at Advarra, provide an overview of the current state of the FDA’s Expanded Access Program and state and federal “Right to Try” legislative efforts.
Certificates of attendance are not currently available for viewing this recorded webinar. If you have questions, please contact email@example.com.